South America Dietary Supplement Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

South America Dietary Supplement Market Trends and Insights

Increased Focus on Preventive Healthcare

In South America, out-of-pocket health expenditures accounted for 32.4% of total health spending, ranking among the highest globally, according to the World Health Organization^{[1]Source: World Health Organization, “Global Health Expenditure Database,” who.int}. This significant financial burden forces households to independently fund wellness interventions, often as a preventive measure to avoid the high costs associated with advanced medical care, as reported by the World Health Organization. Non-communicable diseases, such as diabetes, hypertension, and cardiovascular disorders, contributed to 77% of deaths in the region, highlighting an urgent demographic need for nutrient-based strategies to mitigate health risks. Additionally, the lack of adequate primary care services in rural and peri-urban areas has further fueled the demand for self-care solutions. Consumers increasingly rely on over-the-counter supplements as a substitute for physician consultations, driven by accessibility challenges and cost considerations. This shift has transformed the role of dietary supplements, positioning them as essential tools for proactive health management rather than optional wellness products. Consequently, this change has significantly influenced both the frequency of purchases and the composition of consumer baskets.

Supplements Targeting Women Consumers Fueling Growth

In 2025, women constituted 35.42% of end-user demand, driven by the growing availability of life-stage-specific formulations tailored to address key health concerns such as prenatal nutrition, menopause management, and bone health. Iron deficiency continues to be a significant issue among women of reproductive age across South America, while calcium and vitamin D supplementation remain critical for preventing osteoporosis in post-menopausal women. Brazil's Rede Cegonha maternal health initiative, supported by the Brazilian Ministry of Health, played a pivotal role in raising awareness about the importance of folic acid and DHA supplementation during pregnancy^{[2]Source: Brazilian Ministry of Health, “Rede Cegonha,” saude.gov.br}. This initiative laid a strong clinical foundation for the growth of commercial prenatal brands. In 2024 and 2025, leading companies such as Nestlé, Bayer, and Abbott expanded their prenatal product portfolios. These companies leveraged endorsements from gynecologists and implemented pharmacy-based educational campaigns to strengthen their market presence. The segment benefits from a higher willingness-to-pay among female consumers, who prioritize products with transparent ingredient lists and clinical validation. This consumer preference enables brands to command premium pricing compared to mass-market multivitamins.

Growing Preference for Clean-Label, Plant-Based and Vegan Formulas

Recent surveys indicate a growing acceptance of plant-based alternatives among consumers, with younger demographics leading this shift due to their focus on sustainability and animal welfare. Millennials and Generation Z, in particular, are highly attentive to product transparency, often examining supplement labels in detail and using mobile apps to cross-check ingredients. These groups are especially attracted to clean-label formulations that exclude synthetic colors, artificial preservatives, and genetically modified ingredients. A significant trend among vegan consumers is the preference for pectin-based gummy vitamins, which have replaced traditional gelatin-based options. Furthermore, botanical extracts such as turmeric, ginger, and echinacea are gaining popularity as natural substitutes for synthetic active ingredients. Despite this growing interest, affordability remains a key challenge. Plant-based supplements are typically priced 15% to 25% higher than conventional alternatives, which limits their accessibility primarily to upper-middle-income households and above.

Healthy-Ageing Focus Accelerating Multivitamin Uptake Among Consumers

In 2024, 15.1% of Brazil's population consisted of individuals aged 60 and above, with this proportion expected to nearly double, reaching 29.4% by 2050. Similarly, Colombia's senior population accounted for 13.9% in 2024 and is projected to rise significantly to 28.6% by 2050. In Argentina, 16.2% of the population fell into this age group in 2024, with forecasts indicating an increase to 24.5% by 2050. This demographic transformation is driving a growing demand for specialized health formulations tailored to the needs of aging populations. Bone-health products that combine calcium, vitamin D, and magnesium are becoming increasingly popular. Joint-support supplements containing glucosamine and chondroitin are also witnessing rising demand, alongside cognitive-health products formulated with omega-3 fatty acids and B-vitamins. Furthermore, multivitamins specifically designed for seniors are addressing challenges related to age-related nutrient malabsorption by incorporating higher concentrations of vitamin B12, folate, and antioxidants. Physician recommendations during routine geriatric consultations play a pivotal role in promoting these products. Such endorsements not only encourage initial trials but also foster repeat purchases, even among older adults who were previously reluctant to adopt supplement use.

Presence of Counterfeit Products Hampering Growth

In January 2026, ANVISA banned four supplement brands for failing to meet safety and quality standards^{[3]Source: ANVISA, “RDC 843/2024,” anvisa.gov.br}. Meanwhile, in October 2025, INVIMA issued Alert 131-2025, cautioning consumers about illegal supplements in Colombia. Counterfeit products not only erode consumer trust in legitimate brands but also amplify the damage when negative media highlights adverse events tied to these substandard formulations. In Brazil, Argentina, and Peru, informal retail channels remain susceptible to unregistered products that lack proper labeling, traceability, or verification of active ingredients. Despite tightening regulations, enforcement gaps endure. Resource-limited agencies find it challenging to inspect cross-border e-commerce shipments and keep tabs on small-scale distributors. When counterfeit versions of their products inflict harm, legitimate manufacturers risk reputational damage. This has led them to invest in anti-counterfeiting technologies, including holographic labels, QR-code authentication, and blockchain-based supply-chain tracking.

Rising Consumer Skepticism Toward Synthetic Additives and Mega-Dose Safety Concerns

Millennials and Generation Z increasingly prefer clean-label products, showing skepticism toward synthetic colors, artificial preservatives, and high-potency formulations perceived as exceeding physiological needs. Reflecting regulatory caution, ANVISA has restricted melatonin supplementation to 0.21 milligrams per day for adults, contrasting with the mega-dose trends prevalent in North American markets. Public health authorities are promoting balanced diets over supplementation through consumer education campaigns, creating challenges for brands marketing products as meal replacements rather than nutritional complements. Safety concerns have grown due to adverse events linked to excessive intake of vitamin A, vitamin D, and iron, leading consumers to seek physician advice before starting supplementation. This trend benefits brands that emphasize clinical validation, transparent ingredient sourcing, and dosage formulations aligned with recommended dietary allowances, while disadvantaging mass-market products that rely on high-potency claims to differentiate themselves.

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

Segment Analysis

By Type: Probiotics Outpace Traditional Categories

In 2025, vitamins and minerals accounted for 28.18% of the market, reflecting strong consumer trust in multivitamins, vitamin C, and calcium supplements. Probiotics, however, are projected to grow at a 7.62% CAGR through 2031 as gut-health science moves from research to mainstream wellness. Bayer's September 2025 launch of Iberoflora probiotics in Latin America, featuring strains like Lactobacillus rhamnosus GG and Bifidobacterium lactis BB-12, underscores the focus on strain-specific formulations backed by clinical trials. In Brazil and Argentina, where traditional medicine remains significant, herbal supplements with botanicals like chamomile, ginger, and turmeric are gaining traction as natural alternatives to synthetic products. Omega-3 fatty acids, derived from fish oil and algae, support cardiovascular and cognitive health, but consumption in South America remains below WHO recommendations due to limited cold-water fish availability and high costs.

Digestive enzymes such as lactase, amylase, and protease address gastrointestinal sensitivities, while collagen peptides, amino acids, and specialized formulations target athletic performance and beauty-from-within needs. Regulatory clarity from ANVISA's Normative Instruction 28/2018, updated multiple times in 2024, has encouraged innovation by defining permissible ingredients, dosages, and health claims while ensuring consumer safety. Probiotics' rapid growth is driven by clinical validation, physician endorsements, and rising awareness of the gut-brain connection, making them a strategic focus for manufacturers aiming to differentiate beyond standard multivitamins.

By Form: Gummies Disrupt Traditional Delivery Formats

In 2025, capsules and softgels accounted for 39.28% of the market share, driven by established manufacturing, precise dosing, and broad consumer acceptance. Gummies, however, are expected to grow at an 8.02% CAGR through 2031, fueled by taste-masking technology and non-pill formats appealing to millennials and pediatric consumers. Gummy production requires specialized equipment and expertise to maintain ingredient stability in humid climates like Brazil and Colombia, creating barriers to entry that benefit established players such as Church & Dwight, Bayer, and Nature's Bounty. Pectin-based gummies have replaced gelatin among vegan consumers, while sugar-free options address concerns about added sugar. However, their premium pricing, 15% to 25% higher than tablets, limits adoption to upper-middle-income households. Tablets remain the most affordable option, attracting price-sensitive consumers and supporting high-potency formulations for larger doses.

Powders serve sports nutrition and meal-replacement needs with dosing flexibility and flavor customization, while liquids cater to pediatric and geriatric populations with swallowing difficulties. Niche formats like effervescent tablets, sublingual strips, and transdermal patches offer convenience or bioavailability benefits, justifying higher prices. Under RDC 843/2024, ANVISA enforces uniform notification requirements across all formats, ensuring gummy manufacturers meet the same standards as capsule producers. The rapid growth of gummies reflects a consumer shift toward wellness products combining efficacy with sensory appeal. This trend pressures established brands to reformulate portfolios or risk losing market share to digitally native brands prioritizing user experience over traditional delivery systems.

By End User: Kids and Children Segment Accelerates

In 2025, women accounted for 35.42% of end-user demand, driven by prenatal, postnatal, menopause, and bone health formulations. Meanwhile, the kids and children segment is expected to grow at a 9.11% CAGR through 2031, as parents increasingly focus on pediatric immunity, cognitive development, and growth support post-pandemic. Despite government fortification efforts, Vitamin A, D, iron, and zinc deficiencies persist among South American children, with stunting remaining a concern in lower-income areas. Picky eating and limited dietary diversity are pushing parents toward multivitamin gummies and chewable tablets, which improve compliance by masking nutrient taste. Regulatory challenges, including age-specific dosing and safety standards, are significant, with ANVISA and INVIMA enforcing strict labeling and marketing rules to prevent overconsumption.

Men represent the other end-user segment, focusing on sports nutrition, testosterone support, and cardiovascular health. However, growth in this segment lags behind women and children due to lower supplement adoption rates and cultural norms discouraging preventive health behaviors. Rising female workforce participation, linked to higher disposable income and health awareness, supports this segment, while intergenerational wealth transfers drive pediatric supplement demand, with grandparents often funding purchases. Brands targeting women and children differentiate themselves through clinical endorsements, pediatrician recommendations, and pharmacy education campaigns, enabling premium pricing and higher margins compared to mass-market multivitamins.

By Distribution Channel: Online Retail Gains Momentum

In 2025, health and wellness stores accounted for 28.62% of the market share, benefiting from specialized products, trained staff, and consumer trust. However, online retail channels are expected to grow at a 7.25% CAGR through 2031, driven by convenience, competitive pricing, and direct-to-consumer fulfillment. Brazil's health and wellness e-commerce reached USD 5.2 billion in 2025, growing 18% year-over-year, led by Mercado Livre, Amazon, Drogasil, and Raia. Supermarkets and hypermarkets offer mass-market access and encourage impulse purchases, while other channels include pharmacies, direct-selling networks like Grupo Omnilife's multi-level marketing, and institutional channels for hospitals and clinics. By 2024, modern retail channels surpassed 50% of total sales, with e-commerce growing 44% in the first half of the year despite macroeconomic challenges.

Online platforms leverage subscription models to boost customer lifetime value and improve inventory predictability. Features like detailed product information, customer reviews, and ingredient transparency align with millennial and Generation Z preferences. Regulatory compliance remains a challenge, as ANVISA's notification requirement under RDC 843/2024 applies to both online and offline channels, necessitating robust quality assurance and traceability systems. Health stores face slower growth due to urban market saturation and competition from pharmacy chains expanding supplement offerings to capture higher-margin categories. Meanwhile, the rapid growth of online retail highlights a structural shift toward digital commerce, set to reshape distribution economics and competition by 2031.

Geography Analysis

In 2025, Brazil accounted for 60.28% of the market share, reaffirming its position as South America's largest economy and most populous nation. The population aged 60 and above, at 15.1% in 2024, is expected to reach 29.4% by 2050, driving demand for bone-health, joint-support, and cognitive-health products. ANVISA's mandatory notification under RDC 843/2024, effective September 1, 2024, increased compliance costs but enhanced product quality and consumer trust by eliminating irregular supplements. Nestlé's USD 224 million investment over three years, announced in October 2025, aims to establish Brazil as a regional innovation hub, with Puravida receiving USD 45 million for product development and export expansion into Mexico and Argentina. 

E-commerce platforms like Mercado Livre, Amazon, Drogasil, and Raia drove health and wellness sales to USD 5.2 billion in 2025, an 18% year-over-year increase, supported by expanded supplement assortments and subscription-based deliveries. Vitamedic's USD 17 million factory in Anápolis, inaugurated in December 2025, plans to triple capacity by 2027, reflecting domestic manufacturing growth to meet rising demand. Colombia is the fastest-growing region, with a 7.36% CAGR through 2031, driven by INVIMA's automatic-registration framework and a growing middle class. The population aged 60 and above, at 13.9% in 2024, is projected to reach 28.6% by 2050, boosting demand for healthy-aging products. INVIMA's Alert 131-2025, issued in October 2025, warned against illegal supplements, reinforcing enforcement to protect legitimate manufacturers. Bayer's September 2025 launch of Iberoflora probiotics in Colombia, following rollouts in Mexico, Guatemala, Costa Rica, and Ecuador, highlights confidence in the market's potential. Argentina, Chile, and Peru hold smaller shares but show unique trends. 

Argentina's population aged 60 and above, at 16.2% in 2024, is expected to reach 24.5% by 2050, driving demand for bone-health and cardiovascular supplements. ANMAT's Disposition 11362/2024 exempted dietary supplements from front-of-pack warning labels, easing regulatory requirements compared to processed foods and beverages. Smaller markets like Paraguay, Uruguay, and Bolivia benefit from cross-border distribution and free-trade agreements but face growth challenges due to limited purchasing power and reliance on informal retail channels.

Regulatory Landscape

Dietary supplements across South America operate under country-specific food and health surveillance regimes, making market entry and portfolio standardization dependent on local sanitary pathways. In Brazil, ANVISA governs supplements under RDC 243/2018, with the region also seeing tighter enforcement via the mandatory notification framework under RDC 843/2024 (effective September 1, 2024), raising the bar for ingredient compliance, labeling, and permitted claims across formats.

Colombia requires sanitary registration for manufacture, import, and commercialization under INVIMA, anchored in Decree 3249 of 2006, while Argentina frames suplementos dietarios within the Argentine Food Code (CAA) under Article 1381 and oversight by ANMAT and CONAL. Ecuador runs a sanitary notification process for supplements via ARCSA, reinforcing the need for multi-country regulatory mapping, local representation, and disciplined claim substantiation to avoid borderline food-drug classifications and enforcement actions.

Market Opportunities and Future Outlook

Local manufacturing scale-up in Brazil is opening whitespace for faster lead times, private label production, and localized formulations that fit country-specific notification and labeling requirements. Concrete capacity signals include Pronutrition announcing an R$ 11 million investment to build a new 8,500 square meter industrial plant in Valinhos, Brazil, targeting a ramp in output capacity up to 18.6 million units per month. The expansion strengthens regional B2B and white-label manufacturing capability, improving supply reliability for brands selling through pharmacies and online platforms.

Opportunity is also forming around clinically positioned and strain- or ingredient-specific products that navigate tighter claim scrutiny while differentiating beyond commodity multivitamins. Probiotics and targeted actives gain distribution leverage through partnerships and regulated launches, illustrated by NVP Healthcare signing an exclusive supply agreement with Brazil's Marjan Farma for a probiotic ingredient and Kyowa Hakko's Setria glutathione entering Chile via a finished product launched by Nutrapharm following SEREMI-related approval steps. With e-commerce already a major route to market in Brazil and enforcement focusing on irregular products, brands that pair compliant dossiers with traceability tools (for example, QR authentication) and pharmacy education can compete more effectively against counterfeit-heavy informal channels.